Essential thrombocythemia: nutritional management in weight loss and malnutrition.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2024
Historique:
received: 26 11 2021
accepted: 19 02 2024
medline: 27 5 2024
pubmed: 27 5 2024
entrez: 27 5 2024
Statut: epublish

Résumé

Essential thrombocythemia is the category of myeloproliferative syndromes, generally characterized by a group of clonal stem cell diseases that present a disturbance in the growth of one or more sets of hematopoietic cells. All long clinical treatment, patients may experience gastrointestinal disorders and other metabolic processes that can lead to weight loss and malnutrition. Cytokine is involved in the control of appetite, digestive, and metabolic processes in the body, it can be assumed that increased stimulation could impair the control of these processes leading to loss of body mass. Effective and systematic nutritional intervention is required to ensure patient compliance with treatment and improved nutritional status.

Identifiants

pubmed: 38799191
doi: 10.11604/pamj.2024.47.93.32594
pii: PAMJ-47-93
pmc: PMC11126749
doi:

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Informations de copyright

Copyright: Isabela de Souza da Costa Brum et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Isabela de Souza da Costa Brum (ISDC)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.
Fluminense Federal University, Niteroi, Rio de Janeiro, RJ, Brazil.

Julia Goncalves (J)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.

Mariana Zanchetta (M)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.

Bruna Xerém (B)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.

Renata Lanziani (R)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.

Marcia Haiut (M)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.

Masato Hada (M)

Hada Clinic, Numazu, Japan.

Alexandre Gustavo Apa (AG)

National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.

Karen Cordovil (K)

Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH